Each year, OCRA honors individuals doing important and notable work in the ovarian cancer field with a research prize to help propel their future discoveries. Individuals are selected by members of OCRA’s Scientific Advisory Committee. Dr. Sarah Adams Awarded Liz Tilberis Research Prize for Outstanding Early Career Investigators The Liz Tilberis Research Prize is awarded … Continued
Most people who dedicate their lives to raising awareness about ovarian cancer, or who dedicate a gift-giving occasion to raise funds for research, have a personal connection to the disease. But for Maite Monardes-Gonzalez, a 15-year-old in Santiago, Chile, that inspiration came from the movies. Ever since she was three, Maite knew she had an … Continued
Spring is almost here and we’re welcoming the warmer weather with a careful and creative return to in-person OCRA Heroes events, including Ovarian Cycle rides and other fitness fundraisers! And many events will still include virtual options, too. A focus on safety–and fundraising Though upcoming events will look a little different than the indoor spin … Continued
As we gear up for our first ever virtual Spring Advocacy Day — which will welcome more than 200 participants, double our usual crowd! — we couldn’t help but take a moment and look back. In a year when the world all but shut down, we accomplished quite a lot on a policy level, thanks … Continued
Imagine, if you will, a scene from yesteryear: rows of telephone operators sitting in front of giant switchboards, lights blinking on and off in seemingly random patterns, hands working quickly to plug and unplug wires in order to foster connections. If you can picture that, you can begin to get a sense of the impact … Continued
PARP inhibitors have proven to be particularly valuable in improving progression-free survival for patients with certain types of ovarian cancer. But unfortunately, these gains come at a high financial cost to many patients, with a recent study showing that Medicare beneficiaries are the hardest hit. A team of researchers from The University of Alabama at … Continued
There are several types of ovarian cancer, and while they may have different origins, treatments, and prognosis, they all affect the ovaries and can be diagnosed with similar tests and procedures. Before going down the path of diagnosis, it’s important to understand that symptoms are not always present with ovarian cancer. A good baseline is … Continued
Updated April 2025: Watch OCRA’s Biomarker Webinars: Most car owners have experienced the frustration of a blinking “check engine” light at one point or another. While the blinking light signals that something is wrong, only the results of diagnostic tests performed by the mechanic can pinpoint exactly what is going on under the hood. In … Continued
It’s not many people who decide to create a tagline for their retirement. Then again, Penny Free is not like many people. Penny is a licensed clinical social worker, an art therapist, and a believer in mantras. The four statements she lives by are: Just do it all; Seek to be inspired; Be of service; … Continued
February 16, 2021 President Joseph R. Biden, Jr.The White House1600 Pennsylvania Avenue, NWWashington, DC 20500 Dear Mr. President: On behalf of a broad spectrum of organizations, cancer centers, and other institutions that represent laboratory, translational, and clinical researchers; other health care professionals; millions of patients with cancer; and patient advocates, we are writing today to … Continued
Those who have faced an ovarian or gynecologic cancer diagnosis have so much to offer to others going through a similar experience – be it support, tips or friendship. “Inspired Advice” is a blog series that tackles specific topics – from what can boost your mood to how to discuss your diagnosis with children – and shares advice … Continued
Dr. Xueyang Yu, of Massachusetts Institute of Technology, is a 2021 recipient of OCRA’s Ann and Sol Mentored Investigator Award. Her project, “Macrophage Control of the Microenvironment Drives HGSOC Progression,” explores how tumor microenvironments influence disease progression for high-grade serous ovarian carcinoma, the most common type of ovarian cancer. What initially sparked your interest in … Continued
Get email updates about research news, action alerts, and ways to join the fight.
A global, Al-powered ecosystem designed to transform gynecologic cancer research—connecting patients, researchers, and clinicians to accelerate breakthroughs.
Our website uses cookies to ensure you get the best experience. By continuing to use this website, you indicate that you have read and agree to our Terms of Use and Privacy Policy.
